D. E. Shaw & Co., Inc. Ironwood Pharmaceuticals Inc Transaction History
D. E. Shaw & Co., Inc.
- $98.6 Billion
- Q2 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 384,949 shares of IRWD stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
384,949
Previous 288,653
33.36%
Holding current value
$1.79 Million
Previous $2.51 Million
0.2%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding IRWD
# of Institutions
247Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$107 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$100 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$76.4 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$43.1 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$41.5 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $714M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...